Search results for “site:nih.gov”
Page 12 of about
453 results
n
ncbi.nlm.nih.gov
pubmed › 33570583
Worldwide, there is an array of clinical trials under way to evaluate treatment options against coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2. Concurrently, several nutritional therapies...
n
ncbi.nlm.nih.gov
pubmed › 33582134
The seasonality of respiratory diseases has been linked, among other factors, to low outdoor absolute humidity and low indoor relative humidity, which increase evaporation of water in the mucosal lining of the respiratory tract. We...
n
ncbi.nlm.nih.gov
pubmed › 33737160
COVID-19 was declared a "Public Health Emergency of International Concern" in March 2020. Since then, drastic measures were implemented to reduce the virus spread. These measures prevented cancer patients from receiving prompt medical...
n
ncbi.nlm.nih.gov
pubmed › 33737894
Coronavirus disease 2019 (COVID-19) is likely to have long-term mental health effects on individuals who have recovered from COVID-19. Rightly, there is a global response for recognition and planning on how to deal with mental health...
n
ncbi.nlm.nih.gov
pubmed › 33777332
Susceptibility to severe illness from COVID-19 is anticipated to be associated with cigarette smoking as it aggravates the risk of cardiovascular and respiratory illness, including infections. This is particularly important with the advent...
n
ncbi.nlm.nih.gov
pubmed › 33834497
The ability of the new coronavirus SARS-CoV-2 to spread and contaminate is one of the determinants of the COVID-19 pandemic status. SARS-CoV-2 has been detected in saliva consistently, with similar sensitivity to that observed in...
n
ncbi.nlm.nih.gov
pubmed › 34033370
Coronavirus disease 2019 (COVID-19), the viral illness caused by the novel coronavirus SARS-CoV-2, has resulted in significant morbidity and mortality worldwide following the identification of the first cases in Wuhan, China, in December...
n
ncbi.nlm.nih.gov
pubmed › 34037382
COVID-19 first appeared in December of 2019 in Wuhan, China. Since then, it has become a global pandemic. A robust and scalable diagnostics strategy is crucial for containing and monitoring the pandemic. RT-PCR is a known, reliable method...
n
ncbi.nlm.nih.gov
pubmed › 34118236
Molnupiravir, a prodrug of the nucleoside derivative β-D-N<sup>4</sup>-hydroxycytidine (NHC), is currently in clinical trials for COVID-19 therapy. However, the biochemical mechanisms involved in molnupiravir-induced mutagenesis had not...
n
ncbi.nlm.nih.gov
pubmed › 34762722
The combination of the ultrasound score and the presence of respiratory failure can easily identify patients with a higher risk to present complications.